porcin
reproduct
respiratori
syndrom
prr
econom
import
diseas
pork
produc
worldwid
commerci
live
kill
prrsv
vaccin
avail
control
prr
alway
success
base
result
mucos
immun
studi
viral
model
good
mucos
vaccin
may
effect
way
elicit
protect
immun
control
prr
outbreak
present
studi
mucos
adjuvant
mycobacterium
tuberculosi
whole
cell
lysat
mtb
wcl
evalu
pig
administ
modifi
live
prr
viru
vaccin
prrsmlv
intranas
mtb
wcl
mediat
increas
frequenc
nk
cell
cell
cell
pig
lung
detect
importantli
increas
earli
gener
prrsv
specif
neutral
antibodi
detect
prrsmlv
mtb
wcl
compar
pig
inocul
vaccin
alon
addit
increas
secret
cytokin
correl
reciproc
reduct
product
immunosuppress
cytokin
well
tregulatori
cell
pig
vaccin
prrsmlv
mtb
wcl
complet
rescu
arginas
level
lung
mediat
mtb
wcl
observ
pig
inocul
prrsmlv
conclus
mtb
wcl
may
potent
mucos
adjuv
prrsmlv
order
potenti
antiprrsv
specif
immun
respons
control
prr
effect
porcin
reproduct
respiratori
syndrom
prr
one
econom
import
chronic
viral
diseas
pig
causal
organ
diseas
prr
viru
prrsv
belong
famili
artevirida
order
nidoviral
clinic
sign
prr
reproduct
failur
abort
high
prewean
mortal
prrsv
caus
immunosuppress
result
suscept
pig
polymicrobi
infect
viru
induc
weak
innat
immun
respons
result
reduc
product
dampen
natur
killer
nk
cell
mediat
cytotox
lead
weakdelay
adapt
immun
respons
although
increas
prrsv
specif
antibodi
gener
earli
postinfect
viru
neutral
vn
antibodi
appear
quit
late
remain
low
level
kill
prrsv
vaccin
avail
fail
provid
adequ
protect
modifiedl
prr
viru
vaccin
prrsmlv
use
control
clinic
prr
young
pig
unfortun
like
prrsv
infect
prrsmlv
also
induc
delay
neutral
antibodi
dampen
cellmedi
immun
cmi
respons
therefor
import
improv
efficaci
prrsv
live
vaccin
control
prr
effect
induct
respons
vaccin
import
viral
clearanc
proinflammatori
cytokin
produc
myeloid
cell
initi
viru
specif
adapt
immun
respons
addit
cmi
respons
manipul
metabol
essenti
amino
acid
larginin
whose
level
bodi
modul
enzym
arginas
nitric
oxid
synthas
role
arginas
viral
infect
respiratori
tract
vaccin
limit
howev
arginas
defici
mice
increas
suscept
viral
infect
requir
arginas
abort
multipl
herp
simplex
viru
hsv
report
contrast
uncontrol
replic
leishmania
correl
enhanc
arginas
activ
mucos
surfac
cover
largest
surfac
area
bodi
almost
total
immun
cell
popul
present
mucos
site
nasopharyng
lymphoid
tissu
contain
entir
repertoir
immun
cell
strateg
locat
orchestr
region
immun
function
airborn
infect
therefor
effect
mucos
vaccin
appropri
strategi
provid
protect
variou
infecti
agent
protect
mucos
immun
mediat
helper
th
cell
cytotox
lymphocyt
ctl
nk
cell
hsv
genit
infect
similarli
intranas
deliveri
influenza
vaccin
flumist
medimmun
gaithersburg
md
provid
immun
compar
induc
natur
infect
ad
advantag
mucos
vaccin
induc
mucos
system
immun
respons
intranas
immun
hivliposom
result
effect
viru
specif
immun
respons
mucos
system
site
increas
efficaci
mucos
immun
potent
adjuv
deliveri
system
need
overcom
immun
toler
mechan
mucos
site
mucos
administr
live
attenu
vaccin
suitabl
adjuv
induc
long
last
protect
variou
studi
perform
bovin
herp
influenza
viru
kill
mycobacterium
tuberculosi
excel
candid
adjuv
use
prepar
freund
complet
adjuv
use
human
food
anim
contraind
due
sever
granulomat
inflammatori
reaction
induc
inject
site
advers
effect
result
toxic
cell
wall
compon
mtb
mycol
acid
arabinogalactan
wax
howev
adjuvant
variou
purifi
compon
mtb
evalu
individu
satisfactori
result
particular
certain
individu
compon
total
fraction
whole
cell
lysat
wcl
mtb
free
toxic
cell
wall
constitu
demonstr
possess
superior
adjuvant
rodent
guinea
pig
rabbit
howev
knowledg
relat
mucos
adjuvant
mtb
wcl
protect
viral
infect
respiratori
tract
limit
purpos
studi
enhanc
efficaci
prrsmlv
help
mtb
wcl
induc
protect
mucos
immun
initi
perform
studi
pig
choos
suitabl
bacteri
candid
use
mucos
adjuv
inocul
nine
differ
bacteri
prepar
belong
mycobacterium
vibrio
streptococcu
speci
intranas
detail
result
present
elsewher
studi
select
mtb
wcl
potent
adjuv
properti
abil
augment
prrsv
specif
cytokin
immun
cell
suppress
immunosuppress
respons
studi
immun
respons
pig
administ
mtb
wcl
intranas
evalu
mucos
system
site
stabl
mycoplasmafre
cell
support
growth
prrsv
use
prepar
prrsv
antigen
perform
immunolog
assay
cell
maintain
dmem
lonza
riversid
ca
fetal
bovin
serum
atlanta
biolog
lawrencevil
ga
c
co
prrsmlv
ingelvac
prr
provid
dr
mike
roof
bior
boehring
ingelheim
vetmedica
inc
st
joseph
mo
wildtyp
prrsv
provid
eric
nelson
south
dakota
state
univers
tuberculosi
whole
cell
lysat
mtb
wcl
provid
dr
dobo
belisl
nihniaid
fund
contract
tb
vaccin
test
research
materi
colorado
state
univers
fort
collin
co
purifi
biotin
label
cytokin
specif
antiporcin
antibodi
r
system
minneapoli
mn
bd
pharmingen
san
diego
ca
invitrogen
camarillo
ca
purchas
commerci
sourc
use
perform
sandwich
elisa
convent
larg
whiteduroc
crossbr
wean
specificpathogenfre
piglet
transport
anim
facil
food
anim
health
research
program
ohio
agricultur
research
develop
center
wooster
oh
swine
herd
confirm
seroneg
antibodi
elisa
prrsv
porcin
respiratori
corona
viru
transmiss
gastroenter
viru
porcin
circo
viru
piglet
bled
arriv
test
confirm
absenc
prrsv
antibodi
pig
allow
acclim
one
week
initi
studi
durat
studi
anim
receiv
food
water
ad
libitum
inocul
adjuv
mtb
wcl
mgpig
vaccin
tcid
per
pig
administ
intranas
pig
maintain
sampl
collect
euthan
per
protocol
approv
institut
anim
care
use
committe
iacuc
institut
biosafeti
committe
ibc
ohio
state
univers
ohio
twentytwo
pig
randomli
alloc
one
three
group
group
mock
pig
n
receiv
normal
salin
ml
group
group
n
vaccin
mtb
wcl
vaccin
adjuv
ml
volum
administ
time
nostril
three
pig
group
euthan
postimmun
day
pid
mock
inocul
pig
n
euthan
separ
prior
euthanasia
vaccin
pig
anoth
studi
data
shown
fig
nine
pig
alloc
three
group
n
per
group
inocul
intranas
mtb
wcl
describ
pig
euthan
pid
mock
inocul
pig
n
euthan
separ
prior
euthanasia
vaccin
pig
three
ml
blood
collect
pid
serum
separ
blood
aliquot
store
c
lung
homogen
prepar
describ
previous
isol
peripher
blood
mononuclear
cell
pbmc
blood
collect
acid
citrat
dextros
solut
isol
bronchoalveolar
lavag
fluid
bal
cell
lung
mononuclear
cell
lung
mnc
mnc
tracheobronchi
lymph
node
tbln
drain
lung
procedur
follow
describ
previous
analyz
prrsv
isotyp
specif
iga
igg
antibodi
serum
elisa
plate
coat
pretitr
crude
kill
prrsv
antigen
gml
carbonatebicarbon
buffer
ph
incub
overnight
c
plate
wash
treat
block
buffer
bsa
pb
h
rt
test
serum
ad
incub
rt
h
plate
wash
bound
prrsv
isotyp
specif
antibodi
detect
use
antipig
iga
antipig
igg
secondari
antibodi
conjug
hrp
kpl
gaithersburg
md
plate
develop
use
chromogen
abt
od
read
nm
elimin
background
activ
control
plate
bicarbon
buffer
ph
without
prrsv
antigen
block
treat
test
serum
develop
separ
od
valu
obtain
control
well
subtract
respect
experiment
well
obtain
correct
valu
standard
indirect
immunofluoresc
assay
ifa
follow
determin
viru
neutral
antibodi
titer
briefli
serum
heat
treat
complement
inactiv
dilut
two
fold
dmem
incub
equal
volum
prrsv
contain
tcid
per
well
h
c
one
hundr
microlit
suspens
transfer
microtit
plate
contain
confluent
monolay
cell
plate
incub
h
c
co
incub
cytopath
effect
examin
follow
fixat
aceton
water
addit
antiprrsv
nucleocapsid
mab
clone
conjug
antimous
igg
hl
secondari
antibodi
cytopath
effect
observ
fluoresc
microscop
mount
glycerolpb
ratio
nk
assay
determin
pig
nkcell
mediat
cytotox
perform
describ
previous
briefli
pbmc
use
sourc
nk
cell
effector
human
myeloblastoid
cell
line
mous
lymphoma
cell
line
target
cell
effector
target
incub
differ
e
ratio
amount
releas
lactat
dehydrogenas
ldh
measur
colorimetr
assay
releas
ldh
directli
proport
nk
specif
lysi
target
cell
five
million
lung
mnc
subject
vitro
restimul
tissu
cultur
plate
presenc
kill
crude
prrsv
antigen
gml
enrich
h
c
harvest
cultur
supernat
analyz
cytokin
elisa
cell
cultur
absenc
antigen
includ
control
amount
cytokin
secret
cell
subtract
respect
restimul
experiment
well
valu
lung
homogen
cell
cultur
supernat
analyz
cytokin
elisa
describ
previous
flow
cytometr
analysi
perform
determin
phenotyp
frequenc
differ
immun
cell
multicolor
immunoassay
describ
previous
immunostain
cell
acquir
use
fac
ariaii
flow
cytomet
bd
bioscienc
analysi
perform
use
flowjo
softwar
tree
star
inc
usa
enumer
differ
immun
cell
popul
base
cell
surfac
marker
express
follow
nk
cell
thelper
cell
cytotox
lymphocyt
ctl
cell
tregulatori
cell
myeloid
cell
frequenc
individu
lymphoid
myeloid
cell
subset
analyz
total
event
colorimetr
assay
use
measur
arginas
level
pig
lung
protocol
standard
base
previous
describ
method
bal
cell
lyse
use
lysi
buffer
contain
proteas
inhibitor
cocktail
min
ice
cell
debri
nuclei
clarifi
centrifug
clear
supernat
aliquot
aliquot
treat
mm
mncl
heat
min
c
anoth
ident
aliquot
treat
mncl
kept
rt
larginin
ph
ad
tube
incub
min
c
reaction
stop
use
mixtur
h
h
po
h
mix
ratio
enzym
activ
measur
ad
heat
treat
min
c
standard
concentr
urea
dilut
ten
fold
subject
similar
treatment
describ
optic
densiti
measur
nm
valu
convert
unit
base
od
valu
urea
standard
one
unit
enzym
activ
defin
amount
enzym
catalyz
format
mol
urea
per
min
data
express
mean
three
six
pig
sem
statist
analys
perform
use
nonparametr
wilcoxon
ttest
function
compar
two
studi
group
pair
ttest
repeat
measur
function
compar
among
differ
pid
sa
softwar
sa
institut
inc
cari
nc
statist
signific
assess
p
initi
pid
prrsv
specif
mtb
wclmediat
adjuv
effect
analyz
pig
lung
homogen
prrsmlv
inocul
pig
significantli
higher
amount
immunosuppress
cytokin
lower
level
proinflammatori
cytokin
fig
also
lungmnc
prrsmlv
inocul
pig
secret
significantli
higher
amount
lower
amount
compar
pig
receiv
prrsmlv
mtb
wcl
fig
indic
system
immun
respons
pbmc
pig
receiv
prrsmlv
secret
anoth
immunosuppress
cytokin
less
respons
induc
cytokin
compar
pig
receiv
prrsmlv
mtb
wcl
fig
increas
immunosuppress
cytokin
respons
associ
signific
increas
frequenc
tregulatori
cell
treg
lung
pig
receiv
prrsmlv
compar
pig
inocul
prrsmlv
mtb
wcl
fig
addit
frequenc
myeloid
cell
tbln
prrsmlv
inocul
pig
significantli
less
fig
particularli
dendrit
cell
dc
rich
fraction
sla
class
ii
data
shown
compar
pig
vaccin
prrsmlv
mtb
wcl
note
mtb
wcl
induc
advers
effect
pig
respiratori
tract
also
perform
vivo
dose
kinet
studi
mtb
wcl
pig
vaccin
intranas
prrsmlv
detect
enhanc
antiprrsv
specif
immun
respons
mtb
wcl
use
mg
per
pig
data
shown
serum
sampl
analyz
prrsv
specif
total
igg
iga
antibodi
surprisingli
significantli
reduc
secr
standard
colorimetr
nk
cell
cytotox
assay
use
determin
nk
cell
function
pbmc
use
effector
target
releas
ldh
measur
use
ldh
substrat
bar
data
point
line
graph
repres
averag
nk
cell
percent
nk
specif
lysi
respect
three
pig
sem
asterisk
denot
statist
signific
differ
pig
inocul
mtb
wcl
tion
igg
pid
detect
pig
receiv
prrsmlv
mtb
wcl
fig
viru
specif
total
iga
secret
also
less
statist
signific
pid
significantli
reduc
pid
pig
vaccin
prrsmlv
mtb
wcl
compar
vaccin
alon
inocul
pig
fig
biii
contrast
prrsv
specif
vn
titer
pid
significantli
higher
prrsmlv
mtb
wcl
vaccin
pig
compar
prrsmlv
alon
inocul
anim
fig
therefor
result
suggest
mtb
wcl
induc
increas
prrsv
specif
vn
titer
prrsmlv
inocul
pig
interestingli
independ
total
prrsv
specif
antibodi
lung
immun
cell
immunostain
identifi
frequenc
nk
cell
signific
increas
frequenc
nk
cell
pid
moder
increas
pid
lung
pig
vaccin
prrsmlv
mtb
wcl
compar
mock
vaccin
alon
receiv
pig
detect
fig
ac
colorimetr
nk
cell
cytotox
assay
perform
detect
moder
rescu
nk
cell
cytotox
e
prrsmlv
mtb
wcl
receiv
pig
pid
fig
increas
frequenc
nk
cell
pid
result
rescu
nk
cell
kill
function
data
shown
lung
mnc
prrsmlv
mtb
wcl
vaccin
pig
secret
significantli
higher
level
cytokin
significantli
reduc
level
immunosuppress
cytokin
pid
compar
pig
receiv
prrsmlv
alon
mockinocul
pig
fig
also
pid
signific
increas
secret
cytokin
moder
reduc
secret
cytokin
lung
mnc
detect
fig
howev
consider
differ
secret
cytokin
observ
pig
group
pid
data
shown
phenotyp
frequenc
variou
lymphoid
immun
cell
pig
analyz
flow
cytometri
frequenc
mockinfect
pig
immun
cell
shown
separ
tabl
lung
prrsmlv
mtb
wcl
vaccin
pig
higher
frequenc
signific
total
lymphocyt
cell
cell
pid
tabl
b
pid
signific
increas
frequenc
cell
detect
lung
prrsmlv
mtb
wcl
vaccin
pig
compar
lung
pig
inocul
prrsmlv
alon
tabl
increas
signific
frequenc
cell
also
detect
tabl
addit
increas
signific
frequenc
cell
lung
prrsmlv
mtb
wcl
vaccin
pig
detect
pid
tabl
contrast
frequenc
treg
lung
prrsmlv
mtb
wcl
vaccin
pig
significantli
less
compar
frequenc
treg
lung
prrsmlv
inocul
pig
pid
tabl
blood
signific
increas
frequenc
cell
detect
pid
prrsmlv
mtb
wcl
inocul
pig
compar
pig
inocul
prrsmlv
alon
tabl
signific
modul
treg
popul
observ
blood
prr
predominantli
diseas
pig
lung
tabl
inform
relat
inhibit
arginas
set
respiratori
viral
infect
andor
vaccin
limit
report
pig
vaccin
intranas
prrsmlv
signif
icantli
reduc
intracellular
arginas
level
lung
pid
compar
physiolog
level
mock
pig
contrast
arginas
level
pig
administ
prrsmlv
mtb
wcl
complet
rescu
interestingli
rescu
significantli
higher
pig
inocul
prrsmlv
pid
fig
repeat
analysi
arginas
pig
receiv
mtb
wcl
pid
also
statist
signific
refer
increas
decreas
lung
arginas
level
respect
fig
three
mockinocul
nine
pig
inocul
prrsmlv
prrsmlv
mtb
wcl
intranas
euthan
pid
n
pig
pid
lymphoid
cell
subset
enumer
flow
cytometri
cell
gate
enumer
express
b
cell
gate
enumer
express
percent
total
cell
shown
number
averag
percent
immun
cell
three
pig
sem
statist
signific
differ
p
mtb
wcl
inocul
pig
group
mark
immunosuppress
respons
observ
pig
inocul
intranas
prrsmlv
alon
like
attribut
induct
treg
increas
level
delay
reduc
secret
well
low
vn
titer
similarli
earlier
studi
also
report
compar
immunosuppress
respons
pig
administ
prrsmlv
also
parenter
rout
apart
delay
respons
prrsv
preferenti
promot
synthesi
nonneutr
antibodi
current
develop
mucos
vaccin
varieti
viral
pathogen
gain
momentum
protect
predomin
mucos
infect
influenza
parainfluenza
respiratori
syncyti
viru
rotaviru
hivsiv
consist
high
degre
compartment
mucos
immun
system
popul
function
distinct
b
cell
cell
accessori
cell
subpopul
compar
popul
present
system
lymphoid
tissu
mucos
immun
system
modul
varieti
mechan
involv
innat
immun
cell
dc
nk
cell
mast
cell
contribut
significantli
host
defens
pathogen
studi
also
demonstr
mechan
induct
mucos
immun
respons
live
inactiv
viral
bacteri
vaccin
help
potent
adjuv
innat
nk
cell
one
major
player
antivir
defens
detect
increas
frequenc
nk
cell
prrsmlv
mtb
wcl
inocul
pig
howev
nk
cell
frequenc
compar
mock
pig
prrsmlv
alon
receiv
pig
find
suggest
prrsv
modul
nk
cell
function
rather
frequenc
pig
lung
nk
cell
play
two
major
role
antivir
defens
secret
cytokin
predominantli
lysi
infect
transform
cell
prrsv
infect
suppress
nk
cell
cytotox
function
pig
recent
studi
pig
experiment
infect
prrsv
show
approxim
reduct
nk
cell
kill
function
two
day
postinfect
dwivedi
renukaradhya
unpublish
data
report
prrsmlv
deliv
intranas
also
suppress
nk
cell
cytotox
function
howev
prrsmlv
administ
mtb
wcl
increas
frequenc
moder
rescu
function
observ
enhanc
product
lung
prrsmlv
mtb
wcl
inocul
pig
detect
earli
pid
critic
augment
innat
nk
cell
function
respons
induct
protect
mucos
immun
intracellular
pathogen
direct
nkdc
crosstalk
mucos
vaccin
anim
adjuv
result
enhanc
innat
adapt
immun
respons
neutral
antibodi
respons
major
compon
protect
immun
prrsv
infect
demonstr
prrsv
infect
induc
polyclon
activ
b
cell
pig
lead
gener
nonneutr
well
autoantibodi
also
prrsvmlv
administ
pig
enhanc
product
nonneutr
antibodi
direct
mainli
prrsvnucleocapsid
protein
intern
viral
protein
also
antibodi
direct
antidecoy
neutral
epitop
viru
detect
contrast
studi
show
reduct
total
prrsv
specif
antibodi
increas
vn
titer
mediat
mtb
wcl
prrsmlv
gener
antibodi
mucos
pathogen
solubl
protein
antigen
depend
th
cell
consist
inform
polar
respons
mediat
via
cell
enhanc
secret
proinflammatori
cytokin
detect
prrsmlv
mtb
wcl
inocul
pig
gener
immun
respons
mutual
suppress
either
one
significantli
upregul
therefor
result
clearli
suggest
mucos
adjuv
mtb
wcl
suppress
secret
prrsv
specif
nonneutr
antibodi
time
promot
secret
neutral
antibodi
critic
prrsv
clearanc
apart
effect
humor
respons
robust
cmi
respons
critic
protect
prrsv
immun
pathogen
specif
mucos
cell
requir
clearanc
intracellular
pathogen
enter
respiratori
mucos
site
consist
detail
prrsmlv
mtb
wcl
receiv
pig
increas
frequenc
cell
secret
cytokin
pig
lung
studi
report
enhanc
immunosuppress
respons
prrsv
infect
pig
mediat
increas
reduc
product
pig
reportedli
inhibit
product
cell
infiltr
treg
infect
pig
lung
microenviron
contribut
secret
high
level
prrsv
infect
pig
increas
frequenc
treg
detect
indic
involv
diseas
progress
immunosuppress
natur
prrsvmlv
also
report
mediat
increas
treg
result
delay
reduc
secret
elicit
protect
cmi
respons
prrsmlv
import
counteract
virusinduc
immunosuppress
respons
studi
mtb
wcl
mediat
increas
frequenc
cell
enhanc
secret
cytokin
counteract
viru
induc
immunosuppress
respons
reciproc
downregul
frequenc
treg
secret
immunosuppress
cytokin
therefor
possibl
protect
pig
prrsv
outbreak
polymicrobi
infect
adapt
mucos
vaccin
strategi
use
potent
adjuv
proinflammatori
cytokin
play
import
role
initi
adapt
immun
respons
influenc
prolifer
profession
antigen
present
cell
macrophag
studi
earli
time
point
pid
significantli
increas
secret
mediat
mtb
wcl
detect
pig
lung
associ
find
signific
increas
myeloid
cell
popul
tbln
pig
vaccin
prrsmlv
mtb
wcl
lymphoid
organ
tbln
site
sensit
activ
immun
cell
take
place
therefor
increas
frequenc
myeloid
cell
tbln
might
indic
mtb
wclmediat
initi
cmi
respons
arginas
help
metabol
larginin
lornithin
subsequ
gener
lprolin
lglutam
lglutamin
physiolog
level
arginas
essenti
bodi
arginas
knockout
mice
die
week
birth
glutamin
import
fuel
lymphocyt
macrophag
plasma
glutamin
decreas
hiv
infect
individu
decreas
level
glutamin
impair
lymphocyt
function
amino
acid
prolin
promot
growth
differenti
bcell
also
nk
cell
activ
therefor
one
immun
dysregul
mechan
prrsv
pig
lung
appear
mediat
downregul
arginas
reduc
intracellular
arginas
detect
pig
inocul
intranas
prrsmlv
therefor
mucos
immun
mtb
wcl
potenti
rescu
import
molecular
mechan
mediat
enzym
arginas
pig
vaccin
prrsmlv
consid
modul
function
arginas
prrsmlv
direct
role
arginas
antiprrsv
specif
mucos
immun
need
investig
detail
conclus
mtb
wcl
consid
potent
mucos
adjuv
prrsmlv
pig
respiratori
tract
adjuv
abil
potenti
innat
humor
cmi
respons
modul
cellular
molecular
mechan
requir
gener
antiprrsv
specif
protect
immun
continu
studi
adjuvant
mtb
wcl
also
confirm
postchalleng
studi
detect
crossprotect
immun
genet
variant
prrsv
consid
fact
prrsmlv
abil
reduc
prrsv
viremia
capabl
provid
partial
protect
may
fruit
approach
use
vaccin
along
mtb
wcl
intranas
abil
mtb
wcl
overcom
immunosuppress
augment
viru
specif
cmi
respons
open
new
avenu
explor
mucos
adjuvant
viral
infect
